- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT04229056
Computerondersteunde zelftraining om de uitvoerende functie te verbeteren (COMPEX)
Computer-Assisted Self-Training to Improve Executive Function Versus Unspecific Training in Patients After Stroke, Cardiac Arrest or in Parkinson's Disease: A Randomized Controlled Trial
This project explores the effects of specialized computer-based cognitive rehabilitation (CBCR) targeting executive functions in three groups of patients: Stroke, Cardiac Arrest and Parkinson's Disease. The effect of specialized CBCR is compared to generally cognitively stimulating activities on a computer
Studie Overzicht
Toestand
Conditie
Gedetailleerde beschrijving
This project explores the effects of specialized computer-based cognitive rehabilitation (CBCR) targeting executive functions in three groups of patients: Stroke, Cardiac Arrest and Parkinson's Disease. The effect of specialized CBCR is compared to completing generally cognitively stimulating activities on a computer. A total of 307 patients is expected to be enrolled. All patients will complete a neuropsychological test battery assessing executive functions at inclusion, directly after the eight-week training period and at follow-up three months after the end of the intervention period. Furthermore, all patients will answer questionnaires concerning quality of life and ADL-measures at baseline, after the intervention and at follow-up. All patients will train for a period of 8 weeks, 5 times a week for 60 minutes regardless of their group allocation.
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
-
Copenhagen, Denemarken
- Rigshospitalet
-
Copenhagen, Denemarken
- Bispebjerg Hospital
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- A diagnose of stroke, cardiac arrest or Parkinson's disease.
- Aged 18 years or older.
- Impaired working memory measured with CABPad working memory test, cut off for inclusion: 5 symbols or less backwards
- Computer and internet access at home.
- Providing informed consent.
Inclusion criteria specific for stroke
- Inclusion within 6 months post-stroke
- Stroke confirmed by clinical findings and imaging, both AIS and ICH is allowed.
- Initial stroke severity >/= NIHSS 3.
Inclusion criteria specific for cardiac arrest
• Inclusion within 6 months post ictus.
Inclusion criteria specific for Parkinson's disease
- Clinical diagnosis of PD.
- Anti-parkinsonian medical treatment (dopaminergic or other).
Exclusion Criteria:
- Informed consent not provided
- Other neurological or psychiatric disease which is expected to influence the patient's ability to participate in the trial according to the investigator
- Not able to participate according to investigator
Exclusion criteria specific for stroke
- Patients with massive anosognosia for executive dysfunction or patients with no subjective feeling of executive dysfunction (Patient sustains total denial of executive symptoms over time)
- Patients with severe aphasia, in which it is unclear whether the patient's performance on a neuropsychological test-battery is due to aphasia and not executive dysfunction.
Exclusion criteria specific for cardiac arrest • None
Exclusion criteria specific for PD
• Diagnosis of PD Dementia according to the MDS PD Dementia criteria
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Specific computer-based cognitive rehabilitation
154 patients will be allocated to specific computer-based cognitive rehabilitation. This group will train with 10 exercises from the cognitive rehabilitation software 'Scientific Brain training PRO'. These 10 exercises are designed to train various executive functions. |
CBCR are software-programmes for computers which are clinically developed for rehabilitation of various cognitive functions. |
|
Actieve vergelijker: General computer-based cognitive stimulation
154 patients will be allocated to general computer-based cognitive stimulation. This group will train with 10 generally mentally stimulating games on a website specifically designed for this trial. These 10 games are chosen because they are believed to have a low load on executive functions but stimulate over-all concentration and visuoperceptual abilities. |
For this trial we have developed a webpage for general cognitive stimulation, which is designed to provide general computer-based cognitive stimulation. |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
CABPad Working Memory Test
Tijdsspanne: After the end of the intervention (8 weeks after baseline)
|
Test of working memory. The higher score the better (theoretically infinite score) |
After the end of the intervention (8 weeks after baseline)
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
CABPad Working Memory Test - 3 months follow-up
Tijdsspanne: At follow-up visit 3 months after end of intervention
|
Test of working memory. The higher score the better (theoretically infinite score) |
At follow-up visit 3 months after end of intervention
|
|
Minimum Data Set-Home Care- Instrumental Activities of Daily Living (MDS-HC-IADL)
Tijdsspanne: At follow-up visit 3 months after the end of the intervention
|
Questionnaire concerning activities of daily living. 0-3 points on an 8-item scale, the fewer points the better. |
At follow-up visit 3 months after the end of the intervention
|
|
Trail Making A
Tijdsspanne: Directly after the intervention, eight weeks after inclusion
|
Test of processing speed and visual attention. The lower score the better (theoretically infinite score) |
Directly after the intervention, eight weeks after inclusion
|
|
Trail Making A
Tijdsspanne: At follow-up visit 3 months after the end of the intervention
|
Test of processing speed and visual attention. The lower score the better (theoretically infinite score) |
At follow-up visit 3 months after the end of the intervention
|
|
Trail Making B
Tijdsspanne: Directly after the intervention, eight weeks after inclusion
|
Test of divided attention, mental flexibility. The lower score the better (theoretically infinite score) |
Directly after the intervention, eight weeks after inclusion
|
|
Trail Making B
Tijdsspanne: At follow-up visit 3 months after the end of the intervention
|
Test of divided attention, mental flexibility. The lower score the better (theoretically infinite score) |
At follow-up visit 3 months after the end of the intervention
|
|
SDMT
Tijdsspanne: Directly after the intervention, eight weeks after inclusion
|
Symbol Digit Modalities Test: Test of mental speed. The higher score the better (theoretically infinite score) |
Directly after the intervention, eight weeks after inclusion
|
|
SDMT
Tijdsspanne: At follow-up visit 3 months after the end of the intervention
|
Symbol Digit Modalities Test: Test of mental speed. The higher score the better (theoretically infinite score) |
At follow-up visit 3 months after the end of the intervention
|
|
Phonological verbal fluency test
Tijdsspanne: Directly after the intervention, eight weeks after inclusion
|
Test of verbal phonological fluency. The higher score the better (theoretically infinite score) |
Directly after the intervention, eight weeks after inclusion
|
|
Phonological verbal fluency test
Tijdsspanne: At follow-up visit 3 months after the end of the intervention
|
Test of verbal phonological fluency. The higher score the better (theoretically infinite score) |
At follow-up visit 3 months after the end of the intervention
|
|
Categorical verbal fluency test
Tijdsspanne: Directly after the intervention, eight weeks after inclusion
|
Test of verbal categorical fluency. The higher score the better (theoretically infinite score) |
Directly after the intervention, eight weeks after inclusion
|
|
Categorical verbal fluency test
Tijdsspanne: At follow-up visit 3 months after the end of the intervention
|
Test of verbal categorical fluency. The higher score the better (theoretically infinite score) |
At follow-up visit 3 months after the end of the intervention
|
|
Fear questionnaire
Tijdsspanne: Directly after the intervention, eight weeks after inclusion
|
Questionnaire with 24 items concerning fear on a scale from 0 to 8 where 8 indicates a higher degree of avoidance due to fear |
Directly after the intervention, eight weeks after inclusion
|
|
Fear questionnaire
Tijdsspanne: At follow-up visit 3 months after the end of the intervention
|
Questionnaire with 24 items concerning fear on a scale from 0 to 8 where 8 indicates a higher degree of avoidance due to fear |
At follow-up visit 3 months after the end of the intervention
|
|
mrs: Modified Rankin Scale
Tijdsspanne: Directly after the intervention, eight weeks after inclusion
|
Questionnaire concerning disability on a scale from 0 (no symptoms) to 6 (dead): Higher score indicates more severe disability. |
Directly after the intervention, eight weeks after inclusion
|
|
mrs: Modified Rankin Scale
Tijdsspanne: At follow-up visit 3 months after the end of the intervention
|
Questionnaire concerning disability on a scale from 0 (no symptoms) to 6 (dead). Higher score indicates more severe disability. |
At follow-up visit 3 months after the end of the intervention
|
|
IQCODE (Informant Questionnaire on Cognitive Decline in the Elderly)
Tijdsspanne: Directly after the intervention, eight weeks after inclusion
|
Cognitive decline in the elderly, reported by partner. A scale of 16 items from 1 (much better) to 5 (much worse). Higher score indicates more severe disability. |
Directly after the intervention, eight weeks after inclusion
|
|
IQCODE (Informant Questionnaire on Cognitive Decline in the Elderly)
Tijdsspanne: At follow-up visit 3 months after the end of the intervention
|
Cognitive decline in the elderly, reported by partner. A scale of 16 items from 1 (much better) to 5 (much worse). Higher score indicates more severe disability. |
At follow-up visit 3 months after the end of the intervention
|
|
EuroQol-5 domain (EQ-5D-5L)
Tijdsspanne: Directly after the intervention, eight weeks after inclusion
|
Quality of life scale with 5 domains, each rated from 1-5 indicating slight to severe disability . Higher score indicates more severe disability. Completed by patient and partner |
Directly after the intervention, eight weeks after inclusion
|
|
EuroQol-5 domain (EQ-5D-5L)
Tijdsspanne: At follow-up visit 3 months after the end of the intervention
|
Quality of life scale with 5 domains, each rated from 1-5 indicating slight to severe disability. Higher score indicates more severe disability. Completed by patient and partner |
At follow-up visit 3 months after the end of the intervention
|
|
PDQ 39 (Parkinsons Disease Questionnaire: Only in patients with Parkinson Disease)
Tijdsspanne: Directly after the intervention, eight weeks after inclusion
|
Quality of Life questionnaire in patients with Parkinson's Disease. A scale with 39 items rated from 1 (never) to 5 (all the time / Can not do at all). Higher score indicates more severe disability. |
Directly after the intervention, eight weeks after inclusion
|
|
PDQ 39 (Parkinsons Disease Questionnaire: Only in patients with Parkinsons Disease)
Tijdsspanne: At follow-up visit 3 months after the end of the intervention
|
Quality of Life questionnaire in patients with Parkinson's Disease. A scale with 39 items rated from 1 (never) to 5 (all the time / Can not do at all). Higher score indicates more severe disability. |
At follow-up visit 3 months after the end of the intervention
|
|
Compliance
Tijdsspanne: Directly after the intervention, eight weeks after inclusion
|
Monitoring of total time spent training in minutes |
Directly after the intervention, eight weeks after inclusion
|
|
PHQ-9 (Patient health questionnaire 9)
Tijdsspanne: Directly after the intervention, eight weeks after inclusion
|
Questionnaire about health of patient with 9 items rated on a 4 point scale from 0 (not at all) to 3 (almost every day). Higher score indicates more severe disability. |
Directly after the intervention, eight weeks after inclusion
|
|
PHQ-9 (Patient health questionnaire 9)
Tijdsspanne: At follow-up visit 3 months after the end of the intervention
|
Questionnaire about health of patient with 9 items rated on a 4 point scale from 0 (not at all) to 3 (almost every day). Higher score indicates more severe disability. |
At follow-up visit 3 months after the end of the intervention
|
|
2) visual analogue scale (1-10)
Tijdsspanne: Directly after the intervention, eight weeks after inclusion
|
After last session: how much they liked doing the training and if they would recommend the intervention to somebody else in their situation. Higher score indicates they liked the training more. |
Directly after the intervention, eight weeks after inclusion
|
|
Minimum Data Set-Home Care- Instrumental Activities of Daily Living (MDS-HC-IADL)
Tijdsspanne: Directly after the intervention, eight weeks after inclusion
|
Questionnaire concerning activities of daily living. 0-3 points on an 8-item scale, the fewer points the better. |
Directly after the intervention, eight weeks after inclusion
|
Medewerkers en onderzoekers
Sponsor
Medewerkers
Onderzoekers
- Hoofdonderzoeker: Hanne Christensen, Professor, Bispebjerg Hospital
Publicaties en nuttige links
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
- Synucleïnopathieën
- Cerebrovasculaire aandoeningen
- Hersenziekten
- Ziekten van het centrale zenuwstelsel
- Ziekten van het zenuwstelsel
- Vaatziekten
- Hart-en vaatziekten
- Psychische aandoening
- Hartziekten
- Neurocognitieve stoornissen
- Cognitieve stoornissen
- Neurodegeneratieve ziekten
- Bewegingsstoornissen
- Parkinson-stoornissen
- Basale ganglia-ziekten
- Hartinfarct
- Cognitieve disfunctie
- Hartstilstand
- Ziekte van Parkinson
Andere studie-ID-nummers
- H-19039236
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
This is currently undecided
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .